3352 results about "Electrode pair" patented technology

A system and method for creating lesions and assessing their completeness or transmurality. Assessment of transmurality of a lesion is accomplished by monitoring the impedance of the tissue to be ablated. Rather than attempting to detect a desired drop or a desired increase impedance, completeness of a lesion is detected in response to the measured impedance remaining at a stable level for a desired period of time, referred to as an impedance plateau. The mechanism for determining transmurality of lesions adjacent individual electrodes or pairs may be used to deactivate individual electrodes or electrode pairs, when the lesions in tissue adjacent these individual electrodes or electrode pairs are complete, to create an essentially uniform lesion along the line of electrodes or electrode pairs, regardless of differences in tissue thickness adjacent the individual electrodes or electrode pairs.

A bipolar forceps is provided and includes a housing having one or more shafts that extend therefrom that operatively support an end effector assembly at a distal end thereof. The end effector assembly includes first and second jaw members. A tissue sealing plate disposed on each of the jaw members is provided. The tissue sealing plates is configured to support a plurality of electrodes thereon and arranged in vertically opposing pairs along the length of the jaw members. The plurality of electrodes is adapted to independently connect to an electrosurgical energy source such that each vertically opposing electrode pairs form an independently controllable electrical circuit when tissue is held between the jaw members. A control system having one or more algorithms for independently controlling and/or monitoring the delivery of electrosurgical energy from the electrosurgical energy source to the plurality of electrodes is also provided.

A system for creating lesions and assessing their completeness or transmurality. Assessment of transmurality of a lesion is accomplished by monitoring the impedance of the tissue to be ablated. Rather than attempting to detect a desired drop or a desired increase impedance, completeness of a lesion is detected in response to the measured impedance remaining at a stable level for a desired period of time, referred to as an impedance plateau. The mechanism for determining transmurality of lesions adjacent individual electrodes or pairs may be used to deactivate individual electrodes or electrode pairs, when the lesions in tissue adjacent these individual electrodes or electrode pairs are complete, to create an essentially uniform lesion along the line of electrodes or electrode pairs, regardless of differences in tissue thickness adjacent the individual electrodes or electrode pairs.

A medical device (5) is provided which comprises a catheter tube having a distal end and a lumen, and configured to assist in applying tamponage to a bleeding source in a gastrointestinal tract when flexed. A catheter tip having a catheter tip outer surface is assembled with the tube adjacent the distal end of the tube. The catheter tip comprises a probe body comprising an electrically insulative material, at least one electrode pair located on the probe body which comprises a first electrode spaced from a second electrode, and a fluid distribution manifold to direct a fluid from inside the probe body towards the tip outer surface. The manifold comprises a central passage within the probe body and a plurality of lateral passages which extend from the central passage towards the tip outer surface. An extendable injection needle is housed within the central passage to provide treatment to tissue.

A memory device comprising a access circuits, an electrode layer over the access circuits, an array of phase change memory bridges over the electrode layer, and a plurality of bit lines over the array of phase change memory bridges. The electrode layer includes electrode pairs. Electrode pairs include a first electrode having a top side, a second electrode having a top side and an insulating member between the first electrode and the second electrode. A bridge of memory material crosses the insulating member, and defines an inter-electrode path between the first and second electrodes across the insulating member.

The invention provides a monitor for measuring blood pressure and other vital signs from a patient without using a cuff. The monitor features a housing with a first surface that, in turn, supports a first sensor. The first sensor features: i) an optical system with one or more light sources (e.g., LEDs or laser diodes) that generate optical radiation, and a photodetector oriented to collect radiation after it irradiates the patient and in response generate an optical signal; and ii) a first electrode. A second sensor features a second electrode paired with the first electrode that collects an electrical signal from the patient. A microprocessor in electrical communication with the first and second sensor receives the optical and electrical signals and processes them with an algorithm to determine systolic and diastolic blood pressure.

A capacitive force sensor (100) includes a substrate (101) having at least one electrode pair (102,103) defining a capacitance disposed thereon. The substrate (101) is fixed relative to a first plate (106). A drive circuit (104) is configured to apply a voltage relative to a circuit ground (105) to the electrode pair (102,103). The first plate (106) is separated from a second plate (107) that is coupled to circuit ground (105) by a compliance member (108,109). The compliance member (108,109) is configured to oppose a compression force (110) while allowing the first plate (106) to physically move relative to the second plate (107). A capacitive detection circuit (111) is then configured to detect a change the capacitance when the compliance member (108,109) is compressed. The compression force (110) is then determined from the change in capacitance and the spring constant of the compliance member (108,109).

Provided is an implantable RFID-enabled micro-electronic neurostimulator system comprising a) an internal subsystem having (i) an array of electrodes, where at least one electrode pair contacts a nerve; (ii) a multiplexer; (iii) digital to analog signal converter; and (iv) a RFID based control and stimulation chip; and (b) an external subsystem having (i) a controller; and (ii) an RF interface.

A semiconductor nanowire is grown laterally. A method of growing the nanowire forms a vertical surface on a substrate, and activates the vertical surface with a nanoparticle catalyst. A method of laterally bridging the nanowire grows the nanowire from the activated vertical surface to connect to an opposite vertical surface on the substrate. A method of connecting electrodes of a semiconductor device grows the nanowire from an activated device electrode to an opposing device electrode. A method of bridging semiconductor nanowires grows nanowires between an electrode pair in opposing lateral directions. A method of self-assembling the nanowire bridges the nanowire between an activated electrode pair. A method of controlling nanowire growth forms a surface irregularity in the vertical surface. An electronic device includes a laterally grown nano-scale interconnection.

A symmetric touch screen switch system in which both the touch side and panelside transparent electrodes are comprised of carbon nanotube thin films is provided. The fabrication of various carbon nanotube enabled components and the assembly of a working prototype touch switch using those components is described. Various embodiments provide for a larger range of resistance and optical transparency for the both the electrodes, higher flexibility due to the excellent mechanical properties of carbon nanotubes. Certain embodiments of the symmetric, CNT-CNT touch switch achieve excellent optical transparency (<3% absorption loss due to CNT films) and a robust touch switching characteristics in an electrical test.